| Bioactivity | GLP-1(32-36)amide TFA, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide TFA could inhibit weight gain and modulate whole body glucose metabolism in diabetic mice[1][2]. |
| Invitro | GLP-1(32-36)amide (0.1-10 μM; 24 h) retains cell viability and decreases apoptosis against Streptozotocin (STZ; 1 μM) in INS‐1 cells[2]. Cell Viability Assay[2] Cell Line: |
| Name | GLP-1(32-36)amide TFA |
| Sequence | Leu-Val-Lys-Gly-Arg-NH2 |
| Shortening | LVKGR-NH2 |
| Formula | C27H51F3N10O7 |
| Molar Mass | 684.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
GLP-1(32-36)amide TFA
CAS: F: C27H51F3N10O7 W: 684.75
GLP-1(32-36)amide TFA, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)ami
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.